MIDO: Integrated Measurement for Early Detection
It allows early and simultaneous detection of kidney disease, diabetes, hypertension and obesity. Thanks to MIDO, the health professional’s team can suggest to a healthy person enrolling on the nephroprevention program, or people with an early stage of kidney disease in the nephroprotection program.
Strategy focused to healthy people and people with risk factors such as obesity, diabetes mellitus, hypertension and cardiovascular disease, in order to prevent the development of kidney disease.
Strategy directed to people who have an early stage of kidney disease, in order to prevent or delay the progression of renal damage. To this end, it includes the use of drugs and sustained lifestyle changes.